108 related articles for article (PubMed ID: 12130845)
1. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting.
Raghavan CV; Muthulingam C; Jenita JA; Ravi TK
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):892-5. PubMed ID: 12130845
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
3. Formulation development and in-vitro/in-vivo correlation for a novel Sterculia gum-based oral colon-targeted drug delivery system of azathioprine.
Nath B; Nath LK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1765-73. PubMed ID: 23110370
[TBL] [Abstract][Full Text] [Related]
4. Studies on stercuia gum formulations in the form of osmotic core tablet for colon-specific drug delivery of azathioprine.
Nath B; Nath LK
PDA J Pharm Sci Technol; 2013; 67(2):172-84. PubMed ID: 23569078
[TBL] [Abstract][Full Text] [Related]
5. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis.
Mundargi RC; Patil SA; Agnihotri SA; Aminabhavi TM
Drug Dev Ind Pharm; 2007 Mar; 33(3):255-64. PubMed ID: 17454058
[TBL] [Abstract][Full Text] [Related]
6. Selective drug delivery to the colon using pectin-coated pellets.
He W; Qing D; Cao DY; Fan LF; Xiang B
PDA J Pharm Sci Technol; 2008; 62(4):264-72. PubMed ID: 19174955
[TBL] [Abstract][Full Text] [Related]
7. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
[TBL] [Abstract][Full Text] [Related]
8. Colon-specific delivery of mesalazine chitosan microspheres.
Varshosaz J; Jaffarian Dehkordi A; Golafshan S
J Microencapsul; 2006 May; 23(3):329-39. PubMed ID: 16801244
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
10. In vitro and human pharmacoscintigraphic evaluation of an oral 5-ASA delivery system for colonic release.
Foppoli A; Maroni A; Moutaharrik S; Melocchi A; Zema L; Palugan L; Cerea M; Gazzaniga A
Int J Pharm; 2019 Dec; 572():118723. PubMed ID: 31628978
[TBL] [Abstract][Full Text] [Related]
11. A novel pH-enzyme-dependent mesalamine colon-specific delivery system.
Jin L; Ding YC; Zhang Y; Xu XQ; Cao Q
Drug Des Devel Ther; 2016; 10():2021-8. PubMed ID: 27382255
[TBL] [Abstract][Full Text] [Related]
12. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.
Wilson PJ; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):89-94. PubMed ID: 16023805
[TBL] [Abstract][Full Text] [Related]
13. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
[TBL] [Abstract][Full Text] [Related]
15. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
Dev RK; Bali V; Pathak K
Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery.
Freire C; Podczeck F; Ferreira D; Veiga F; Sousa J; Pena A
J Pharm Pharmacol; 2010 Jan; 62(1):55-61. PubMed ID: 20722999
[TBL] [Abstract][Full Text] [Related]
18. A Biopredictive In Vitro Comparison of Oral Locally Acting Mesalazine Formulations by a Novel Dissolution Model for Assessing Intraluminal Drug Release in Individual Subjects.
Karkossa F; Klein S
J Pharm Sci; 2018 Jun; 107(6):1680-1689. PubMed ID: 29499277
[TBL] [Abstract][Full Text] [Related]
19. Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.
Cheng G; An F; Zou MJ; Sun J; Hao XH; He YX
World J Gastroenterol; 2004 Jun; 10(12):1769-74. PubMed ID: 15188503
[TBL] [Abstract][Full Text] [Related]
20. Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.
Omwancha WS; Mallipeddi R; Valle BL; Neau SH
Int J Pharm; 2013 Jan; 441(1-2):343-51. PubMed ID: 23200955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
